Belluscura taps into Hong Kong market
By HME News Staff
Updated 8:56 AM CDT, Wed September 27, 2023
LONDON and PLANO, Texas – Belluscura has received approval from the Hong Kong Department of Health – Medical Device Division to distribute its X-PLOR portable oxygen concentrator. The company has already received its first purchase order from a Hong Kong distributor. "We are very excited to receive the approval and begin sales in Hong Kong,” said Bob Rauker, CEO of Belluscura. “I am very pleased with our operations, quality control and sales teams receiving approval ahead of schedule. Hong Kong is phase one of our joint expansion with Innomax into Asia." Hong Kong is part of the licensed territory in its exclusive agreement signed last month with Innomax Medical Device Technologies. Belluscura has also announced it has successfully completed a patient usability study for its DISCOV-R POC, with all participants providing positive feedback on the device. The company will start initial production of the device this week and plans full-scale production, in conjunction with Innomax, in response to significant preliminary demand.
Comments